Nigel Rozario

4PUBLICATIONS
11CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 27, 2025
Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar's Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9.

Amit Bahl, Andrew Chilelli, Rita Faria

|Aug 01, 2025
Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study.

Amit Bahl, Andrew Chilelli, Rita Faria

|Apr 21, 2025
Attributes and Health Care Resource Utilization of Patients on Enzalutamide or Abiraterone for Metastatic Castration-Resistant Cancer in England.

Amit Bahl, Rita Faria, Axel S Merseburger

|Apr 21, 2023
Treatment patterns, healthcare resource utilization and costs of HER2-negative gastric/gastroesophageal junction cancer.

Rupali Fuldeore, Leonardo Passos Chaves, Qi Feng

Pageof 1

Frequent Collaborators

3 joint publications

Amit Bahl

3 joint publications

Rita Faria

2 joint publications

Andrew Chilelli

2 joint publications

Robert Snijder